Retatrutide (GLP-3RT)
Triple-incretin research peptide studied across GLP-1, GIP, and glucagon receptor pathways.
Mechanism
GLP-3RT engages GLP-1, GIP, and glucagon receptors in parallel. In research models this multi-agonism is studied for its combined effects on insulin secretion, satiety signaling, lipolysis, and energy expenditure.
Discovery
Emerged from the multi-agonist incretin research program that followed dual GLP-1/GIP work in the late 2010s. Represents the next generation of poly-agonist metabolic research compounds.
Research Status
Active area of preclinical and translational metabolic research. Long-acting profile makes it a common reference tool in comparative energy-balance studies.
Quality Notes
Peptide integrity and mass-spec confirmation are essential. Ares Retatrutide (GLP-3RT) ships with third-party COA and is stored cold from synthesis through fulfillment.
Related research
Track your research with Ares One.